# FMC Corp: Form 10-Q for the period ended Sep 30, 2014

- Company: [FMC Corp](/companies/fmc.md) (CIK 37785)
- Form: 10-Q
- Filed: 2014-10-30
- Accepted by EDGAR: Oct 30, 2014, 17:27 ET
- Period: 2014-09-30
- Accession: 0000037785-14-000045
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/37785/000003778514000045/fmc930201410q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/37785/000003778514000045/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2014-07-01 to 2014-09-30 | $1.02bn | us-gaap:Revenues |
| Revenue | 9 months, 2014-01-01 to 2014-09-30 | $2.95bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2014-07-01 to 2014-09-30 | $692.2m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2014-01-01 to 2014-09-30 | $1.94bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2014-07-01 to 2014-09-30 | $323.7m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2014-01-01 to 2014-09-30 | $1.01bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2014-07-01 to 2014-09-30 | $147.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2014-01-01 to 2014-09-30 | $391.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2014-07-01 to 2014-09-30 | $103.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2014-01-01 to 2014-09-30 | $459.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2014-07-01 to 2014-09-30 | $7.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2014-01-01 to 2014-09-30 | $88.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2014-07-01 to 2014-09-30 | $56.3m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2014-01-01 to 2014-09-30 | $231.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2014-07-01 to 2014-09-30 | $0.42 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2014-01-01 to 2014-09-30 | $1.72 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2014-07-01 to 2014-09-30 | $0.42 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2014-01-01 to 2014-09-30 | $1.73 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2014-07-01 to 2014-09-30 | 134,345,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2014-01-01 to 2014-09-30 | 134,285,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2014-01-01 to 2014-09-30 | $234.6m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months, 2014-01-01 to 2014-09-30 | $172.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2014-01-01 to 2014-09-30 | $58.1m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2014-01-01 to 2014-09-30 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2014-09-30 | $124.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2014-09-30 | $2.86bn | us-gaap:AssetsCurrent |
| Total assets | at 2014-09-30 | $5.25bn | us-gaap:Assets |
| Current liabilities | at 2014-09-30 | $1.74bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2014-09-30 | $1.15bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2014-09-30 | $18.7m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2014-09-30 | $561.7m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2014-09-30 | $1.72bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2014-09-30 | 133,267,021 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 67,889 characters.

Item 2 of this report contains certain forward-looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information.

Whenever possible, we have identified these forward-looking statements by such words or phrases as “will likely result”, “is confident that”, "expect", “expects”, “should”, “could”, “may”, “will continue to”, "believe", “believes”, “anticipates”, “predicts”, “forecasts”, “estimates”, “projects”, “potential”, “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the section “Forward-Looking Statements” in Part II of our Annual Report on Form 10-K for the year ended December 31, 2013 (the “2013 10-K”) and to similar disclaimers in all other reports and forms filed with the Securities and Exchange Commission (“SEC”). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.

We further caution that the list of risk factors in Item 1A in Part I of the 2013 10-K may not be all-inclusive, and we specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

### APPLICATION OF CRITICAL ACCOUNTING POLICIES

Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We have described our accounting policies in Note 1 to our consolidated financial statements included in our 2013 10-K. We have reviewed these accounting policies, identifying those that we believe to be critical to the preparation and understanding of our consolidated financial statements. We have reviewed these critical accounting policies with the Audit Committee of our Board of Directors. Critical accounting policies are central to our presentation of results of operations and financial condition and require management to make estimates and judgments on certain matters. We base our estimates and judgments on historical experience, current conditions and other reasonable factors.

The following is a list of those accounting policies that we have deemed most critical to the presentation and understanding of our results of operations and financial condition. See the “Application of Critical Accounting Policies” section in our 2013 10-K for a detailed description of these policies and their potential effects on our results of operations and financial condition.

- Environmental obligations and related recoveries
- Impairment and valuation of long-lived assets
- Pensions and other postretirement benefits
- Income taxes

We did not adopt any changes in the current period that had a material effect on these critical accounting policies nor did we make any changes to our accounting policies that would have changed these critical accounting policies.

### RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS AND REGULATORY ITEMS

See Note 2 to our condensed consolidated financial statements included in this Form 10-Q for a discussion of recently adopted accounting guidance and other new accounting guidance.

### OVERVIEW

We are a diversified chemical company serving agricultural, consumer and industrial markets globally with innovative solutions, applications and market-leading products. We operate in three distinct business segments: FMC Agricultural Solutions, FMC Health and Nutrition and FMC Minerals. Our FMC Agricultural Solutions segment develops, markets and sells all three major classes of crop protection chemicals – insecticides, herbicides and fungicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as in non-agricultural markets for pest control. The FMC Health and Nutrition segment focuses on food, pharmaceutical ingredients, nutraceuticals, personal care and similar markets. Our nutrition ingredients are used to enhance texture, color, structure and physical stability. The health additives are used for binding, encapsulation and disintegrant applications. Our FMC Minerals segment manufactures a wide range of inorganic materials, including soda ash and lithium. Soda ash is utilized in markets such as glass and detergents and lithium is utilized in energy storage, specialty polymers and pharmaceutical synthesis.

### Third Quarter 2014 Highlights

The following are the more significant developments in our businesses during the three months ended September 30, 2014:

- Revenue of $1,015.9 million for the three months ended September 30, 2014 increased $58.5 million or six percent versus the same period last year. The increase in revenue was driven by all three of our segments. A more detailed review of revenues by segment is discussed under the section titled "Results of Operations". On a regional basis, sales in North America remained flat, sales in Asia were up eight percent, Latin America sales increased by ten percent and sales in Europe, Middle East and Africa were up five percent.
- Our gross margin, excluding acquisition/divestiture related charges, increased by approximately $17 million or approximately six percent to $323.7 million versus the prior year's quarter. Gross margin percent remained flat at 32 percent. The increase in gross margin did not result in increased gross margin percent primarily due to unfavorable currency movements and product mix of sales in FMC Agricultural Solutions.
- Selling, general and administrative expenses, excluding non-operating pension and postretirement charges and acquisition/divestiture related charges decreased by approximately $6.2 million or five percent to $108.4 million. The decrease period over period is primarily due to a decrease in employees' incentive accruals in 2014.
- Research and Development expenses of $30.6 million increased approximately $2 million or 6 percent. This increase is primarily related to spending in FMC Agricultural Solutions to fund investments in earlier stage active ingredient research, biological crop protection development projects and rapid market innovation initiatives.
- Adjusted after-tax earnings from continuing operations attributable to FMC stockholders of $127.5 million increased $17.3 million or 16 percent primarily due to higher operating results in all three segments. See the disclosure of our Adjusted Earnings Non-GAAP financial measurement below, under the section titled "Results of Operations".

### Other Highlights

- On September 8, 2014, we announced that we will no longer proceed with the planned separation of FMC into two distinct public entities. At that time we announced the planned acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division.
- Our FMC Agricultural Solutions segment entered into an exclusive license, development and supply agreement for a novel crop protection product for agricultural use in the United States.
- In October 2014 we purchased the remaining 6.25 percent ownership interest from the last remaining non-controlling interest holder in a legal entity within our FMC Alkali Chemicals division, which increased our ownership from 93.75 percent to 100 percent. We paid $21.4 million to the minority shareholder in the nine months ended September 30, 2014. An additional $77.1 million was paid in October 2014.
- Also in October 2014, we entered into a $2.0 billion term loan facility for the purposes of funding the acquisition of Cheminova A/S and amended our $1.5 billion revolving credit facility in conjunction with the term loan facility.

### RESULTS OF OPERATIONS

### Overview

The following presents a reconciliation of our segment operating profit to the net income attributable to FMC stockholders as seen through the eyes of our management. For management purposes, we report the operating performance of each of our business segments based on earnings before interest and income taxes excluding corporate expenses, other income (expense), net and corporate special income/(charges).

*SEGMENT RESULTS RECONCILIATION*

*(in Millions)*

| 2014 Revenue | Three Months Ended September 30 | 2013 | Nine Months Ended September 30 2014 | 2013 |
| --- | ---: | ---: | ---: | ---: |
| FMC Agricultural Solutions | $548.8 | $530.2 | $1,546.9 | $1,468.0 |
| FMC Health and Nutrition | 203.1 | 190.4 | 636.4 | 572.2 |
| FMC Minerals | 264.0 | 237.8 | 762.2 | 706.8 |
| Eliminations | — | (1.0) | — | (2.9) |
| Total | $1,015.9 | $957.4 | $2,945.5 | $2,744.1 |
| **Income (loss) from continuing operations before income taxes** |  |  |  |  |
| FMC Agricultural Solutions | $116.7 | $114.2 | $367.5 | $402.2 |
| FMC Health and Nutrition | 43.7 | 41.1 | 143.7 | 129.1 |
| FMC Minerals | 39.2 | 27.7 | 118.8 | 92.1 |
| Eliminations | — | (0.1) | — | (0.3) |
| **Segment operating profit** | $199.6 | $182.9 | $630.0 | $623.1 |
| Corporate and other | (15.3) | (20.1) | (52.4) | (60.2) |
| **Operating profit before the items listed below** | $184.3 | $162.8 | $577.6 | $562.9 |
| Interest expense, net | (14.9) | (9.8) | (43.7) | (31.4) |
| Corporate special (charges) income: |  |  |  |  |
| Restructuring and other (charges) income (1) | (35.6) | (32.1) | (45.0) | (47.3) |
| Non-operating pension and postretirement charges (2) | (1.5) | (5.7) | (8.4) | (30.0) |
| Business separation costs (3) | (6.8) | — | (23.6) | — |
| Acquisition/divestiture related charges (4) | (37.5) | (6.7) | (41.7) | (6.7) |
| Provision for income taxes | (7.4) | (32.0) | (88.2) | (113.1) |
| Discontinued operations, net of income taxes | (20.5) | (56.6) | (83.2) | (58.3) |
| Net income attributable to noncontrolling interests | (3.8) | (2.0) | (12.8) | (9.3) |
| **Net income attributable to FMC stockholders** | $56.3 | $17.9 | $231.0 | $266.8 |

(1) See Note 8 within our accompanying condensed consolidated financial statements for details of restructuring and other charges (income). Amounts for the three months ended September 30, 2014, relate to FMC Agricultural Solutions of $17.0 million, FMC Minerals of $0.1 million and Corporate of $18.5 million. Amounts for the three months ended September 30, 2013, relate to FMC Agricultural Solutions of $30.7 million, FMC Health and Nutrition of $0.1 million, FMC Minerals of $0.3 million and Corporate of $1.0 million. Amounts for the nine months ended September 30, 2014, relate to FMC Agricultural Solutions of $17.0 million, FMC Health and Nutrition of $5.9 million, FMC Minerals of $0.1 million and Corporate of $22.0 million. Amounts for the nine months ended September 30, 2013, relate to FMC Agricultural Solutions of $32.6 million, FMC Health and Nutrition of $0.8 million, FMC Minerals of $9.6 million and Corporate of $4.3 million.

(2) Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs from our segments as we believe that removing them provides a better understanding of the underlying profitability of our businesses, provides increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in our operating segments noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees. These expenses are included as a component of the line item “Selling, general and administrative expenses” on our condensed consolidated statements of income.

(3) Charges are associated with the previously planned separation of our FMC Corporation into two independent public companies. See Note 4 in our condensed consolidated financial statements filed in this Form 10-Q for more detail on the business separation costs. These charges are included within "Business separation costs" on our condensed consolidated income statement. These costs were primarily related to professional fees associated with separation activities within the finance and legal functions.

(4) Charges related to the expensing of the inventory fair value step-up resulting from the application of purchase accounting, legal and professional fees and gains or losses on hedging purchase price associated with the planned or completed acquisitions and costs incurred associated with the potential divestiture of our FMC Alkali Chemicals division. Amounts represent the following:

*(in Millions)*

| Acquisition related charges - Cheminova A/S | Three Months Ended September 30 2014 | 2013 | Nine Months Ended September 30 2014 | 2013 |
| --- | ---: | ---: | ---: | ---: |
| Legal and professional fees (1) | $15.2 | $— | $15.2 | $— |
| Unrealized loss/(gain) on hedging purchase price (1) | 21.2 | — | 21.2 | — |
| Acquisition related charges - Epax |  |  |  |  |
| Legal and professional fees (1) | — | 4.6 | — | 4.6 |
| Inventory fair value step-up amortization (2) | — | 2.1 | 4.2 | 2.1 |
| Divestiture related charges - FMC Alkali Chemicals division |  |  |  |  |
| Legal and professional fees (1) | 1.1 | — | 1.1 | — |
| **Acquisition/divestiture related charges** | **$37.5** | **$6.7** | **$41.7** | **$6.7** |

(1) On the condensed consolidated statements of income, these charges are included in “Selling, general and administrative expenses.”

(2) On the condensed consolidated statements of income, these charges are included in “Costs of sales and services.”

The following chart, which is provided to assist the readers of our financial statements, depicts certain after-tax charges (gains). These items are excluded by us in the measures we use to evaluate business performance and determine certain performance-based compensation. These after-tax items are discussed in detail within the “Other results of operations” section that follows. Additionally, the chart below discloses our Non-GAAP financial measure “Adjusted after-tax earnings from continuing operations attributable to FMC stockholders” reconciled from the GAAP financial measure “Net income attributable to FMC stockholders”. We believe that this measure provides useful information about our operating results to investors and securities analysts. We also believe that excluding the effect of restructuring and other income and charges, non-operating pension and postretirement charges, certain tax adjustments from operating results and discontinued operations allows management and investors to compare more easily the financial performance of our underlying businesses from period to period. This measure should not be considered as a substitute for net income (loss) or other measures of performance or liquidity reported in accordance with GAAP.

*ADJUSTED EARNINGS RECONCILIATION*

*(in Millions)*

| 2014 | Three Months Ended September 30 | 2013 | Nine Months Ended September 30 2014 | 2013 |
| --- | ---: | ---: | ---: | ---: |
| **Net income attributable to FMC stockholders (GAAP)** | $56.3 | $17.9 | $231.0 | $266.8 |
| Corporate special charges (income), pre-tax | 81.4 | 44.5 | 118.7 | 84.0 |
| Income tax expense (benefit) on Corporate special charges (income) | (28.1) | (16.2) | (41.2) | (31.1) |
| Corporate special charges (income), net of income taxes | $53.3 | $28.3 | $77.5 | $52.9 |
| Discontinued operations, net of income taxes | 20.5 | 56.6 | 83.2 | 58.3 |
| Tax expense (benefit) adjustments | (2.6) | 7.4 | (1.6) | 9.1 |
| **Adjusted after-tax earnings from continuing operations attributable to FMC stockholders (Non-GAAP)** | $127.5 | $110.2 | $390.1 | $387.1 |

In the discussion below, please refer to our chart titled "Segment Results Reconciliation" within the Results of Operations section. All comparisons are between the periods unless otherwise noted.

### Segment Results

For management purposes, segment operating profit is defined as segment revenue less operating expenses (segment operating expenses consist of costs of sales and services, selling, general and administrative expenses and research and development expenses). We have excluded the following items from segment operating profit: corporate staff expense, interest income and expense associated with corporate debt facilities and investments, income taxes, gains (or losses) on divestitures of businesses, restructuring and other charges (income), non-operating pension and postretirement charges, investment gains and losses, loss on extinguishment of debt, asset impairments, Last-in, First-out ("LIFO") inventory adjustments, acquisition related charges, and other income and expense items.

Information about how each of these items relates to our businesses at the segment level and results by segment is discussed in Note 20 of our condensed consolidated financial statements filed in this Form 10-Q and in Note 20 of our consolidated financial statements in our 2013 Form 10-K.

### FMC Agricultural Solutions

*($ in Millions)*

| 2014 | Three Months Ended September 30 | 2013 | Nine Months Ended September 30 2014 | 2013 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $548.8 | $530.2 | $1,546.9 | $1,468.0 |
| Operating Profit | 116.7 | 114.2 | 367.5 | 402.2 |

### Three Months Ended September 30, 2014 vs. 2013

Revenue of $548.8 million increased approximately four percent versus the prior year quarter due to higher sales in Latin America.

In Latin America, sales were $391.2 million, up nine percent, driven by increased demand for pre-emergent herbicides in Argentina to control resistant weeds, increased fungicide and insecticide sales in Mexico into fruits and vegetable segments and higher sales of recently-introduced products in Brazilian soybeans and cotton; these sales were partially offset by continued drought conditions in Brazil that reduced demand for herbicides and insecticides into the sugarcane segment. In North America, sales were $63.0 million, down seven percent, primarily due to weak pest pressures in the Midwestern United States. Asian sales were $69.7 million, down seven percent, primarily related to drought conditions in India, lower sales in Thailand due to the cessation of rice crop subsidy, and other Asian countries that had reduced demand. Sales in Europe, Middle East and Africa (EMEA) decreased 12 percent to $24.9 million due to timing of shipments into cocoa, partially offset by strong demand for herbicides in Europe.

FMC Agricultural Solutions' operating profit of $116.7 million increased approximately two percent compared to the prior year quarter. Higher volumes and improved product mix were partially offset by increased hedging and logistics costs. Selling, general and administrative ("SG&A") costs were approximately $2 million lower, and research and development ("R&D") costs were approximately $1 million higher than the prior-year quarter, with spending focused on technology investments.

### Nine Months Ended September 30, 2014 vs. 2013

Revenue of $1,546.9 million increased approximately five percent versus the prior year period due to sales growth across all regions despite unfavorable weather conditions during the first half of the year in North America and the persistent drought conditions in Brazil.

Latin America sales of $734.3 million increased five percent. North America sales of $452.2 million increased six percent and EMEA sales of $112.5 million increased four percent. Revenue in Asia of $247.9 million increased six percent.

FMC Agricultural Solutions' operating profit of $367.5 million decreased approximately nine percent compared to the prior year period, reflecting unfavorable currency impacts, planned increases to SG&A as well as R&D costs and weather-related changes in product mix. SG&A costs were approximately $10 million higher and R&D costs were approximately $5 million higher than the prior year period with spending on marketing, sales and technology investments.

In 2014, we expect full-year segment revenue to increase mid-single digits percentage reflecting increased volumes from new and recently introduced products in nearly all markets. Full-year segment operating profit is expected to be mid-single digits percentage lower than 2013. Higher sales are expected to be offset by first half unfavorable product mix and weather conditions in North America and Brazil, foreign exchange impacts and planned investments in sales, marketing and R&D.

#### Certain Regulatory Issues

We intend to defend vigorously all our products in the U.S., EU and other countries as our pesticide products are reviewed in the ordinary course of regulatory programs during 2014 as part of the ongoing cycle of re-registration of our pesticide products around the world. In early 2014, the Brazilian health surveillance agency informed us that they intend to complete their review of carbofuran along with several other major pesticides by the end of this year, but the agency has not yet issued any required formal announcement that identifies their specific concerns or preliminary position on re-registration. We are co-operating and defending our product in this process. Under the Brazilian regulatory process, any recommendation would require public notice and comment as well as concurrence from the Brazilian environmental and agricultural ministries before any regulatory change is effective. Thus, we do not expect any material sales impact due to this Brazilian regulatory review during 2014.

### FMC Health and Nutrition

*($ in Millions)*

| 2014 | Three Months Ended September 30 | 2013 | Nine Months Ended September 30 2014 | 2013 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $203.1 | $190.4 | $636.4 | $572.2 |
| Operating Profit | 43.7 | 41.1 | 143.7 | 129.1 |

### Three Months Ended September30, 2014 vs. 2013

Revenue was $203.1 million, an increase of approximately seven percent versus the prior-year quarter. The revenue increase was due to higher sales into health end markets, particularly pharmaceutical excipients, slightly offset by weaker demand for nutrition products in Asia. Favorable product mix increased revenue by four percent, higher prices contributed two percent and higher volume and favorable currency combined increased revenue by one percent.

Segment operating profit of $43.7 million increased six percent versus the prior-year quarter. Favorable product mix, price increases in nutrition products and higher volumes in health products were partially offset by increased raw material costs, particularly seaweed, and increased hedging costs.

### Nine Months Ended September 30, 2014 vs. 2013

Revenue was $636.4 million, an increase of approximately 11 percent versus the prior year period. Revenue from higher volumes in health markets, including acquisitions completed in 2013, increased sales by approximately one and eight percent, respectively. Favorable pricing, primarily in nutrition-related products, and currency impacts increased sales by one percent each.

Segment operating profit of $143.7 million increased 11 percent versus the prior year period driven by higher volumes in the health markets, including contributions from new omega-3 products and favorable pricing in nutrition products. These were slightly offset by increased raw material costs and higher SG&A costs. SG&A costs increased by $1.6 million or three percent over the prior period.

In 2014, full year segment revenue is expected to increase high-single digits percentage versus 2013 primarily driven by higher volumes in texture and stability solutions, natural colors and binder lines and contributions from the omega-3 product line. Segment earnings are expected to increase high-single digits percentage over 2013 as a result of the increased demand for functional ingredients and benefits from new omega-3 sales.

### FMC Minerals

*($ in Millions)*

| 2014 | Three Months Ended September 30 | 2013 | Nine Months Ended September 30 2014 | 2013 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $264.0 | $237.8 | $762.2 | $706.8 |
| Operating Profit | 39.2 | 27.7 | 118.8 | 92.1 |

### Three Months Ended September 30, 2014 vs. 2013

Revenue was $264.0 million, an increase of approximately 11 percent versus the prior-year quarter.

Alkali revenues of $196.8 million increased nine percent. Higher pricing and freight contributed four percent revenue growth while volume gains increased revenue by an additional five percent versus the third quarter of 2013 when the mine experienced unusually high insoluble content.

Lithium revenues of $67.2 million increased 19 percent. Improved operations produced additional volumes and resulted in 21 percent sales growth, which was partially offset by unfavorable currency impact of two percent.

Segment operating profit of $39.2 million increased approximately 42 percent versus the prior-year quarter. Operations in both Alkali and Lithium remain very strong with production volumes at record levels. Higher volumes in both businesses along with favorable soda ash pricing drove the improved profitability. Higher energy costs in Alkali continued to be offset by manufacturing cost improvements.

### Nine Months Ended September 30, 2014 vs. 2013

Revenue was $762.2 million, an increase of approximately eight percent versus the prior-year period. Volume gains in Alkali and Lithium along with improvements in soda ash pricing contributed to the higher revenue.

Alkali revenues of $574.6 million increased four percent compared to the period year period. Both higher average prices and volume increases contributed a two percent increase in revenue. The most notable price increases were realized in Asian export markets.

Lithium revenues of $187.6 million increased 24 percent due to higher production volume that allowed for additional sales, particularly for energy storage applications.

Segment operating profit of $118.8 million increased approximately 29 percent versus the prior-year period. Operating profit was driven by higher volumes, improved pricing and lower operating costs in Alkali as well as higher volumes in Lithium . These increases were partially offset by unfavorable currency associated with Lithium’s Argentine operations and higher energy costs in Alkali.

In 2014, we expect full-year segment revenue to increase mid- to high-single digits percentage driven primarily by increased volumes in both lithium and soda ash and short- and long-term contracted price increases in soda ash. Full-year segment operating profit in 2014 is expected to increase in the low twenties percentage versus the previous year, reflecting more favorable soda ash pricing along with lithium margin improvements.

### Other Results of Operations

#### Corporate and other

Corporate and other expenses are included as a component of the line item “Selling, general and administrative expenses” except for last-in, first-out (LIFO) related charges that are included as a component of "Cost of sales and services" on our condensed consolidated statements of income.

### Three Months Ended September 30, 2014 vs. 2013

Corporate and other expenses of $15.3 million in the third quarter of 2014 decreased by $4.8 million from $20.1 million in the same period in 2013. The decrease period over period is primarily due to a decrease of $5.4 million in employees' incentive accruals in 2014.

### Nine Months Ended September 30, 2014 vs. 2013

Corporate and other expenses of $52.4 million in the nine months of 2014 decreased by $7.8 million from $60.2 million in the same period in 2013. The decrease is period over period is primarily due to a decrease of $6.7 million in employees' incentive accruals in 2014.

#### Interest expense, net

### Three Months Ended September 30, 2014 vs. 2013

Interest expense, net for the third quarter of 2014 was $14.9 million as compared to the third quarter of 2013 of $9.8 million. The increase was primarily due to higher overall long-term debt levels driven by funding requirements for the acquisition of Epax and increased working capital requirements, see chart included below.

*Average Long-Term Debt*

*(in Millions)*

|  |  |  |  |
| --- | ---: | --- | ---: |
| June 30, 2014 | $1,172.6 | June 30, 2013 | $784.2 |
| September 30, 2014 | 1,170.6 | September 30, 2013 | 795.0 |
| **Average for the three months ended September 30, 2014** | **$1,171.6** | **Average for the three months ended September 30, 2013** | **$789.6** |

40

### Nine Months Ended September 30, 2014 vs. 2013

Interest expense, net for the nine months of 2014 was $43.7 million as compared to the nine months of 2013 of $31.4 million. The increase is consistent with the description provided for the three months ended September 30, 2014, see chart included below for average long-term debt.

*Average Long-Term Debt*

*(in Millions)*

|  |  |  |  |
| --- | ---: | --- | ---: |
| December 31, 2013 | $1,188.8 | December 31, 2012 | $914.5 |
| September 30, 2014 | 1,170.6 | September 30, 2013 | 795.0 |
| **Average for the nine months ended September 30, 2014** | **$1,179.7** | **Average for the nine months ended September 30, 2013** | **$854.8** |

#### Corporate special (charges) income

### Three Months Ended September 30, 2014 vs. 2013

#### Restructuring and other charges (income)

*(in Millions)*

|  | Three Months Ended September 30 2014 | 2013 | Nine Months Ended September 30 2014 | 2013 |
| --- | ---: | ---: | ---: | ---: |
| Restructuring charges and asset disposals | $1.3 | $0.5 | $8.0 | $12.2 |
| Other charges (income), net | 34.3 | 31.6 | 37.0 | 35.1 |
| Total restructuring and other charges | $35.6 | $32.1 | $45.0 | $47.3 |

Restructuring and asset disposal charges in 2014 of $1.3 million were primarily associated with miscellaneous exit costs and severance payments. Other charges (income) net in 2014 of $34.3 million were primarily related to corporate environmental charges and charges associated with an exclusive license, development and supply agreement for a novel crop protection product for agricultural use in the United States. The rights and technology obtained is referred to as in-process research and development and in accordance with GAAP, the amounts paid were expensed as incurred since they were acquired outside of a business combination.

Restructuring and asset disposal charges in 2013 of $0.5 million were primarily associated with the previously announced Lithium restructuring. Other charges (income) net in 2013 of $31.6 million were charges associated with three transactions in our Agricultural Solutions segment for the purpose of obtaining certain technology and intellectual property rights relating to new compounds still under development. The rights and technology obtained is referred to as in-process research and development and in accordance with GAAP, the amounts paid were expensed as incurred since they were acquired outside of a business combination.

The liabilities associated with the restructuring charges listed above are also included within Note 8 to our condensed consolidated financial statements included in this Form 10-Q. We believe the restructuring plans implemented are on schedule and the benefits and savings either have been or will be achieved.

#### Non-operating pension and postretirement charges

The charge for the three months ended September 30, 2014 was $1.5 million compared to $5.7 million for the three months ended September 30, 2013. The decrease was primarily the result of a settlement charge of $7.1 million in 2013 compared to a settlement charge of $0.5 million in 2014. The settlement charge is associated with the acceleration of previously deferred pension actuarial losses and was triggered by a lump-sum payout to certain former executives. See Note 16 within the condensed consolidated financial statements included within this Form 10-Q.

#### Business separation costs

On September 8, 2014, we announced that we will no longer proceed with the planned separation of FMC into two distinct public entities. At that time we announced the planned acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division. See Note 4 within the condensed consolidated financial statements included in this Form 10-Q for more detail on the business separation costs. Costs for the three months ended September 30, 2014 were incurred through September 8, 2014. We do not expect any additional costs to be incurred.

#### Acquisition/divestiture related charges

Charges incurred for the three months ended September 30, 2014 are associated with the planned acquisition of Cheminova A/S and the divestiture of our FMC Alkali Chemicals division. See Note 3 within the condensed consolidated financial statements included in this Form 10-Q for additional detail. The charges for the three months ended September 30, 2013 relate to a number of acquisitions completed in 2012 and 2013. Detailed description of the acquisition/divestiture related charges is included in Note 20 to the condensed consolidated financial statements in this Form 10-Q.

### Nine Months Ended September 30, 2014 vs. 2013

#### Restructuring and other charges (income)

Restructuring and asset disposal charges in 2014 of $8.0 million were primarily associated with the announced Health and Nutrition restructuring. Other charges (income), net in 2014 of $37.0 million were primarily related to the items associated with the three months ended September 30, 2013, as discussed previously.

Restructuring and asset disposal charges in 2013 of $12.2 million were primarily associated with the previously announced Lithium restructuring. Other charges (income), net in 2013 of $35.1 million were primarily related to the items associated with the three months ended September 30, 2013, as discussed previously.

#### Non-operating pension and postretirement charges

The charge for the nine months ended September 30, 2014 was $8.4 million compared to $30.0 million for the nine months ended September 30, 2013. The decrease was primarily the result of lower amortization of actuarial losses. The change was also a result of a settlement charge of $7.1 million in 2013 compared to a settlement charge of $4.1 million in 2014, as discussed previously.

#### Business separation costs

On September 8, 2014, we announced that we will no longer proceed with the planned separation of FMC into two distinct public entities. At that time we announced the planned acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division. See Note 4 within the condensed consolidated financial statements included in this Form 10-Q for more detail on the business separation costs. Costs for the nine months ended September 30, 2014 were incurred through September 8, 2014. We do not expect any additional costs to be incurred.

#### Acquisition/divestiture related charges

A detailed description of the acquisition/divestiture related charges is included in Note 20 to the condensed consolidated financial statements in this Form 10-Q.

#### Provision for income taxes

### Three Months Ended September 30, 2014 vs. 2013

Provision for income taxes was $7.4 million resulting in an effective tax rate of 8.4 percent compared to a provision of $32.0 million resulting in an effective tax rate of 29.5 percent for the three months ended September 30, 2014 and 2013, respectively. The primary drivers for the decreased effective tax rate in 2014 compared to 2013 are provided in the tables below. Excluding the items listed below the effective rate for is 22.3 percent compared to 23.0 percent for the three months ended September 30, 2014 and 2013, respectively. The fluctuation in the effective tax rate, excluding the items listed below between current year and prior year is primarily the result of the change in the mix of domestic income compared to income earned outside of the U.S. Earnings from our domestic operations are generally taxed at a higher tax rate than that of our foreign operations.

*(in Millions)*

| Select discrete tax items: | Three Months Ended September 30 2014 Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate % Impact | 2013 Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate % Impact |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Business separation costs (1) | $(6.8) | $(2.5) |  | $— | $— |  |
| Acquisition/divestiture related charges (2) | (37.5) | (11.8) |  | (6.7) | (1.9) |  |
| Tax only discrete items (3) | — | (7.8) |  | — | 7.4 |  |
| Total tax benefit of items above | $(44.3) | $(22.1) | 13.9% | $(6.7) | $5.5 | (6.5)% |

(1) Charges associated with the previously planned separation of FMC see Note 20, within the condensed consolidated financial statements included in this Form 10-Q for more information.

(2) Charges associated with the planned acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division, see Note 20 within the condensed consolidated financial statements included in this Form 10-Q for more information.

(3) Represents the tax effect of currency remeasurement associated with our foreign operations that in accordance with GAAP income tax accounting guidance shall be treated discretely for tax purposes. Amounts also include revisions to our tax liabilities associated with prior year tax matters. The tax charges in 2013 were associated with the sale of our discontinued FMC Peroxygens business as well as revisions to our tax liabilities associated with prior year tax matters.

### Nine Months Ended September 30, 2014 vs. 2013

Provision for income taxes was $88.2 million resulting in an effective tax rate of 21.2 percent compared to a provision of $113.1 million resulting in an effective tax rate of 25.3 percent for the nine months ended September 30, 2014 and 2013, respectively. The primary drivers for the decreased effective tax rate in 2014 compared to 2013 are provided in the tables below. Excluding the items listed below the effective rate is 24.3 percent compared to 23.3 percent for the nine months ended September 30, 2014 and 2013, respectively. The fluctuation in the effective tax rate, excluding the items listed below between current year and prior year is consistent with the three months discussion above.

*(in Millions)*

| Select discrete tax items: | Nine Months Ended September 30 2014 Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate % Impact | 2013 Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate % Impact |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Business separation costs (1) | $(23.6) | $(8.7) |  | $— | $— |  |
| Acquisition/divestiture related charges (2) | (41.7) | (12.9) |  | (6.7) | (1.9) |  |
| Tax only discrete items (3) | — | (6.8) |  | — | 9.1 |  |
| Total tax benefit of items above | $(65.3) | $(28.4) | 3.1% | $(6.7) | $7.2 | (2.0)% |

(1) Charges associated with the previously planned separation of FMC see Note 20, within the condensed consolidated financial statements included within this Form 10-Q for more information.

(2) Charges associated with the planned acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division, see Note 20 within the condensed consolidated financial statements included in this Form 10-Q for more information.

(3) Represents the tax effect of currency remeasurement associated with our foreign operations that in accordance with GAAP income tax accounting guidance shall be treated discretely for tax purposes. Amounts also include revisions to our tax liabilities associated with prior year tax matters. The tax charges in 2013 were associated with the sale of our discontinued FMC Peroxygens business as well as revisions to our tax liabilities associated with prior year tax matters.

#### Discontinued operations, net of income taxes

Our discontinued operations represent our discontinued FMC Peroxygens business results as well as adjustments to retained liabilities from previous discontinued operations. The primary liabilities retained include environmental liabilities, other postretirement benefit liabilities, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities. For more information on our Discontinued operations, net of income taxes, see Note 11 to the condensed consolidated financial statements included in this Form 10-Q.

### Three Months Ended September 30, 2014 vs. 2013

Discontinued operations, net of income taxes represented a loss of $20.5 million for the three months ended September 30, 2014, compared to a loss of $56.6 million for the three months ended September 30, 2013. The loss for 2014 was driven by provisions for environmental liabilities of $14.3 million and legal reserves of $3.6 million. The loss for 2013 was a result of a charge of $65.0 million ($50.8 million after tax) associated with FMC Peroxygens primarily to adjust the FMC Peroxygens assets held for sales downward to fair value.

### Nine Months Ended September 30, 2014 vs. 2013

Discontinued operations, net of income taxes represented a loss of $83.2 million for the nine months ended September 30, 2014, compared to a loss of $58.3 million for the nine months ended September 30, 2013. The increased loss in 2014 was driven by provisions for environmental liabilities of $26.6 million and legal reserves of $11.2 million and the final divestiture charge on the sale of our FMC Peroxygens business of $40.0 million.

#### Net income attributable to FMC stockholders

### Three Months Ended September 30, 2014 vs. 2013

Net income attributable to FMC stockholders increased to $56.3 million for the three months ended September 30, 2014, from $17.9 million for the three months ended September 30, 2013. The increase was primarily driven by increased operating profits provided by all three of our operating segments, a lower effective tax rate, and lower charges from discontinued operations. These benefits were slightly offset by increased costs incurred assocated with our planned acquisition of Cheminova A/S.

### Nine Months Ended September 30, 2014 vs. 2013

Net income attributable to FMC stockholders decreased to $231.0 million for the nine months ended September 30, 2014, from $266.8 million for the nine months ended September 30, 2013. The decrease was driven by costs associated with our previously planned business separation, the planned acquisition of Cheminova A/S, higher interest expense and loss to discontinued operations driven by the loss on the sale of our FMC Peroxygens business. Slightly offsetting these higher costs were improvements in our segment operating profits, lower effective tax rate and lower non-operating pension and postretirement charges.

### LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents at September 30, 2014 and December 31, 2013, were $124.3 million and $123.2 million, respectively. Of the cash and cash equivalents balance at September 30, 2014, $118.7 million were held by our foreign subsidiaries. Our intent is to reinvest permanently the earnings of our foreign subsidiaries and therefore we have not recorded taxes that would be payable if we repatriated these earnings.

At September 30, 2014, we had total debt of $1,732.3 million as compared to $1,851.9 million at December 31, 2013. Total debt included $1,151.9 million and $1,154.1 million of long-term debt (excluding current portions of $18.7 million and $34.7 million) at September 30, 2014 and December 31, 2013, respectively. Short-term debt, which consists primarily of borrowings under our commercial paper program, decreased from $663.1 million at December 31, 2013 to $561.7 million at September 30, 2014. Our commercial paper program allows us to borrow at rates generally more favorable than those available under our credit facility. We have used proceeds from the commercial paper program for general corporate purposes. At September 30, 2014, the average effective interest rate on these borrowings was 0.33%.

### Term Loan Facility

On October 10, 2014, we entered into a term loan agreement (the “Term Loan Agreement”), that provides for a senior unsecured term loan facility of up to $2 billion (the “Term Loan Facility”) to consummate the acquisition of Cheminova (the "Acquisition"). The Term Loan Facility is a senior unsecured obligation that ranks equally with our other senior unsecured obligations. The proceeds of the loans to be made pursuant to the Term Loan Facility will be available in one or more drawings on the closing date of the Term Loan Facility, which will be substantially concurrent with the closing of the Acquisition. The scheduled maturity of the Term Loan Facility is on the fifth anniversary of this closing date. The proceeds will be used to finance the Acquisition as well as to pay fees and expenses incurred in connection with the Acquisition and the other transactions contemplated by or related to the Acquisition or the Term Loan Facility.

Loans under the Term Loan Agreement will bear interest at a floating rate, which will be a base rate or a Eurocurrency rate equal to the London interbank offered rate for the relevant interest period, plus in each case an applicable margin, as determined in accordance with the provisions of the Term Loan Agreement. The base rate will be the highest of: the rate of interest announced publicly by Citibank, N.A. in New York, New York from time to time as its “base rate”; the federal funds effective rate plus 1/2 of 1 percent; and the Eurocurrency rate for a one-month period plus 1 percent.

We are required to pay a commitment fee on the average daily unused amount from October 10, 2014 until the date on which all commitments are terminated, payable quarterly, at a rate per annum equal to an applicable percentage in effect from time to time for commitment fees. The initial commitment fee is 0.125 percent per annum. The applicable margin and the commitment fee are subject to adjustment as provided in the Term Loan Agreement.

The Term Loan Agreement contains financial and other covenants, including a maximum leverage ratio and minimum interest coverage ratio. Fees incurred to secure the Term Loan Facility have been deferred and will be amortized over the term of the arrangement.

### Revolving Credit Facility

On October 10, 2014 we entered into an amended and restated credit agreement (the "Revolving Credit Agreement"). The unsecured Revolving Credit Agreement provides for a $1.5 billion revolving credit facility, with an option, subject to certain conditions and limitations, to increase the aggregate amount of the revolving credit commitments to $2.25 billion (the "Revolving Credit Facility"). The current termination date of the Revolving Credit Facility is October 10, 2019.

Revolving loans under the Revolving Credit Facility will bear interest at a floating rate, which will be a base rate or a Eurocurrency rate equal to the London interbank offered rate for the relevant interest period, plus, in each case, an applicable margin, as determined in accordance with the provisions of the Revolving Credit Agreement. The base rate will be the highest of: the rate of interest announced publicly by Citibank, N.A. in New York, New York from time to time as its “base rate”; the federal funds effective rate plus 1/2 of 1 percent; and the Eurocurrency rate for a one-month period plus 1 percent. We are also required to pay a facility fee on the average daily amount (whether used or unused) at a rate per annum equal to an applicable percentage in effect from time to time for the facility fee, as determined in accordance with the provisions of the Revolving Credit Agreement. The initial facility fee is 0.125 percent per annum. The applicable margin and the facility fee are subject to adjustment as provided in the Revolving Credit Agreement.

The Revolving Credit Agreement contains customary financial and other covenants, including a maximum leverage ratio and minimum interest coverage ratio. The financial covenant levels have been amended in order to permit the debt incurred under the contemplated Term Loan Facility discussed above along with certain other changes to permit the Acquisition and the planned divestiture of our FMC Alkali Chemicals division.

Fees incurred to secure the Revolving Credit Facility have been deferred and will be amortized over the term of the arrangement.

### Statement of Cash Flows

*Cash provided by operating activities was $234.6 million and $380.6 million for the nine months ended September 30, 2014 and 2013, respectively.*

The table below presents the components of net cash provided (required) by operating activities.

*(in Millions)*

| 2014 | Nine Months Ended September 30 | 2013 |
| --- | ---: | ---: |
| Income from continuing operations before equity in (earnings) loss of affiliates, interest income and expense and income taxes | $459.5 | $479.4 |
| Significant non-cash expenses (1) | 132.3 | 154.1 |
| **Operating income before non-cash expenses (Non-GAAP)** | **$591.8** | **$633.5** |
| Change in trade receivables (2) | (95.7) | (93.9) |
| Change in inventories (3) | (78.3) | (14.0) |
| Change in accounts payable | 1.8 | 0.6 |
| Change in accrued rebates (4) | 143.0 | 194.8 |
| Change in advance payments from customers (5) | (174.8) | (122.1) |
| Change in all other operating assets and liabilities (6) | 59.8 | 18.7 |
| Restructuring and other spending (7) | (6.6) | (8.8) |
| Environmental spending, continuing, net of recoveries (8) | (9.1) | (4.3) |
| Pension and other postretirement benefit contributions (9) | (65.2) | (63.1) |
| **Cash basis operating income (Non-GAAP)** | **$366.7** | **$541.4** |
| Interest payments | (43.2) | (29.5) |
| Tax payments (10) | (84.5) | (124.6) |
| Excess tax benefits from share-based compensation | (4.4) | (6.7) |
| **Cash provided (required) by operating activities** | **$234.6** | **$380.6** |

(1) Represents the sum of depreciation, amortization, non-cash asset write downs, share-based compensation, and pension charges.

(2) Overall, the increase in trade receivables in each year is primarily due to revenue increases, particularly for FMC Agricultural Solutions in Brazil where terms are significantly longer than the rest of our business, as well as due to timing of payments.

(3) The change in inventory from 2013 to 2014 resulted in a use of cash primarily due to an inventory build to fulfill projected demand in the second half of 2014 in FMC Agricultural Solutions and FMC Health and Nutrition.

(4) These rebates are primarily associated with our FMC Agricultural Solutions segment, both in North America and Brazil. The change from 2013 to 2014 is primarily associated with the mix in sales eligible for rebates and incentives in 2014 compared to 2013 as well as timing of payment of rebates.

(5) The advance payments from customers represent advances from our FMC Agricultural Solutions segment customers. The use of cash for each year presented is consistent with our sales increases year over each year.

(6) Changes in all periods presented primarily represent timing of payments associated with all other operating assets and liabilities, including guarantees issued to our vendors under our vendor finance program.

(7) See Note 8 in the condensed consolidated financial statements included in this Form 10-Q for further details.

(8) The amounts in this row represent environmental remediation spending at our operating sites which were recorded against pre-existing reserves, net of recoveries. Included in our results are environmental charges for environmental remediation at our operating sites of for the three and nine months ended September 30, 2014 of $17.3 million and $20.0 million, respectively and $1.0 million and $3.0 million, respectively for the three and nine months ended September 30, 2013. The amounts in 2014 will be spent in periods beyond third quarter 2014.

(9) Amounts include voluntary contributions to our U.S. defined benefit plan of $50.0 million and $40.0 million, respectively for the nine months ended September 30, 2014 and 2013.

(10) The reduction in tax payments from 2013 to 2014 is due to December 31, 2013 domestic prepaid tax balance that was utilized in the first quarter of 2014, thereby reducing tax payments in 2014 compared to 2013.

*Cash required by operating activities of discontinued operations was $32.9 million and $31.4 million for the nine months ended September 30, 2014 and 2013, respectively.*

The increase in cash required by operating activities of discontinued operations in 2014 is due to increased spending associated with our other discontinued reserves which primarily includes retained legal obligations. This increased spending was slightly offset by reduced net spending associated with discontinued environmental remediation sites.

*Cash required by investing activities of continuing operations was $197.9 million and $555.3 million for the nine months ended September 30, 2014 and 2013, respectively.*

The decrease in spending during the nine months ended September 30, 2014, as compared to the same period in 2013 was primarily due to the Epax acquisition that was completed in third quarter of 2013, slightly offset by higher spending on capital expenditures in 2014 compared to 2013 to support growth initiatives.

*Cash provided (required) by investing activities of discontinued operations was $198.5 million and $(15.2) million for the nine months ended September 30, 2014 and 2013, respectively.*

Cash provided by investing activities of discontinued operations in 2014 is directly associated with the sale of our FMC Peroxygens business which was completed on February 28, 2014. For more information see Note 11 in our condensed consolidated financial statements included in this Form 10-Q.

*Cash provided (required) by financing activities was $(199.6) million and $253.7 million for the nine months ended September 30, 2014 and 2013, respectively.*

The change period over period in financing activities is primarily due to less short-term borrowings in 2014 compared to borrowings in 2013. In 2013, increased borrowings were approximately $751 million compared to repayments in 2014 of $119 million. Additionally during the nine months ended 2013 we paid approximately $367 million in share repurchases and $90 million to noncontrolling interests (primarily to acquire additional ownership in our FMC Alkali Chemicals division) compared to approximately $26 million in combined payments in 2014.

### Other potential liquidity needs

On September 8, 2014, we announced that we will no longer proceed with the planned separation of FMC into two distinct public entities. At that time we announced the planned acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division. For the three and nine months ended September 30, 2014, $6.8 million and $23.6 million, respectively in expense was recognized and included within "Business separation costs" on the condensed consolidated statement of income included in this Form 10-Q. These costs were primarily related to professional fees associated with separation activities within finance and legal functions. We do not expect to incur any additional charges beyond September 8, 2014.

On September 8, 2014, we announced the planned acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division. Pursuant to the terms and conditions set forth in the purchase agreement for the acquisition of Cheminova A/S, we have agreed to acquire all of the outstanding equity of Cheminova for approximately $1.5 billion excluding net debt of approximately $0.3 million as of September 30, 2014. We expect to complete the acquisition in early 2015. On October 10, 2014, we entered into a term loan agreement, that provides for a senior unsecured term loan facility of up to $2 billion to consummate the acquisition of Cheminova. We also entered into an amended and restated credit agreement. The unsecured revolving credit agreement provides for a $1.5 billion revolving credit facility, with an option, subject to certain conditions and limitations, to increase the aggregate amount of the revolving credit commitments to $2.25 billion. See the Liquidity and Capital Resources section above for additional information on the term loan agreement and the amended and restated revolving credit agreement.

Our cash needs for 2014, outside of the planned Cheminova acquisition, include operating cash requirements, capital expenditures, scheduled mandatory payments of long-term debt, dividend payments, share repurchases, contributions to our pension plans, environmental and asset retirement obligation spending and restructuring. We plan to meet our liquidity needs through available cash, cash generated from operations, commercial paper issuances and borrowings under our committed revolving credit facility. At September 30, 2014, our remaining borrowing capacity under our credit facility was $867.1 million (which reflects borrowings under our commercial paper program).

Projected 2014 capital expenditures as well as expenditures related to contract manufacturers are expected to be flat to lower than 2013 levels, as increased capital expenditures in FMC Minerals will be offset by a reduction in FMC Health and Nutrition.

Projected 2014 spending includes approximately $20 million to $30 million of net environmental remediation spending. The gap in the range of projected net environmental remediation spending is due to the uncertainty around the timing of recovery payments to be received from third party insurance policies or or other third parties. This spending does not include expected spending of approximately $10 million in 2014 on capital projects relating to environmental control facilities. Also, we expect to spend approximately $30 million in 2014 for environmental compliance costs, which we will include as a component of costs of sales and services in our condensed consolidated statements of income since these amounts are not covered by established reserves. Capital spending to expand, maintain or replace equipment at our production facilities may trigger requirements for upgrading our environmental controls, which may increase our spending for environmental controls over the foregoing projections.

In order to reduce future funding volatility in our U.S. qualified defined benefit pension plan (U.S. Plan), we have made voluntary contributions through September 30, 2014 and 2013 of $50.0 million and $40.0 million, respectively. We do not expect to make any further voluntary cash contributions to our U.S. defined benefit pension plan during 2014. All contributions in 2014 and 2013 are in excess of the minimum requirements. Total voluntary contributions in 2013 were $40 million. We do not believe that these contributions will have a material negative impact on our current and future liquidity needs. However, any volatility of interest rates or negative equity returns may require greater contributions to the U.S. Plan in the future.

For the nine months ended September 30, 2014 and 2013, we paid $58.1 million and $55.6 million, respectively, in dividends declared in previous periods. On October 16, 2014, we paid dividends totaling $20.1 million to our shareholders of record as of September 30, 2014. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheet as of September 30, 2014.

During the nine months ended September 30, 2014, we did not repurchase any shares under the publicly announced repurchase program. At September 30, 2014, $250 million remained unused under our Board-authorized repurchase program. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. We also reacquire shares from time to time from employees in connection with the vesting, exercise and forfeiture of awards under our equity compensation plans.

### Commitments and Contingencies

See Note 19 to the condensed consolidated financial statements included in this Form 10-Q.

### Contractual Commitments

Information related to our contractual commitments at December 31, 2013 can be found in a table included within Part II, Item 7 of our 2013 Form 10-K. There have been no material changes to our contractual commitments during the nine months ended September 30, 2014.

### Climate Change

A detailed discussion related to climate change can be found in Part II, Item 7 of our 2013 Form 10-K. There have been no material changes related to climate change from the information reported in our 2013 10-K.

### Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

### Fair-Value Measurements

See Note 18 to our condensed consolidated financial statements in this Form 10-Q for additional discussion surrounding our fair value measurements.

### DERIVATIVE FINANCIAL INSTRUMENTS AND MARKET RISKS

Our earnings, cash flows, and financial position are exposed to market risks relating to fluctuations in commodity prices, interest rates and foreign currency exchange rates. Our policy is to minimize exposure to our cash flow over time caused by changes in commodity, interest and currency exchange rates. To accomplish this, we have implemented a controlled program of risk management consisting of appropriate derivative contracts entered into with major financial institutions.

The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. The range of changes chosen reflects our view of changes that are reasonably possible over a one-year period. Market-value estimates are based on the present value of projected future cash flows considering the market rates and prices chosen.

At September 30, 2014, our financial instrument position was a net asset of $3.7 million compared to a net liability of $6.4 million at December 31, 2013. The change in the net financial instrument position was primarily due to larger unrealized losses in our commodity and foreign exchange portfolios.

Since our risk management programs are generally highly effective, the potential loss in value for each risk management portfolio described below would be largely offset by changes in the value of the underlying exposure.

### Commodity Price Risk

Energy costs are diversified among coal, electricity, and natural gas. We attempt to mitigate our exposure to increasing energy costs by hedging the cost of future deliveries of natural gas and by entering into fixed-price contracts for the purchase of coal and fuel oil. To analyze the effect of changing energy prices, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in energy market prices from their levels at September 30, 2014 and December 31, 2013, with all other variables (including interest rates) held constant.

*(in Millions)*

|  | Net Asset / (Liability) Position | Hedged energy exposure vs. Energy market pricing 10% Increase | 10% Decrease |
| --- | ---: | ---: | ---: |
| **Net asset/(liability) position at September 30, 2014** | $0.6 | $2.5 | $(2.0) |
| **Net asset/(liability) position at December 31, 2013** | $0.1 | $3.0 | $(2.7) |

Our FMC Agricultural Solutions segment enters into contracts with certain customers in Brazil to exchange our products for future physical delivery of soybeans. To mitigate the price risk associated with these barter contracts, we enter into offsetting derivatives to hedge our exposure. As of September 30, 2014 and December 31, 2013 we had no outstanding soybean derivative contracts.

### Foreign Currency Exchange Rate Risk

The primary currencies for which we have exchange rate exposure are the U.S. dollar versus the euro, the U.S. dollar versus the Chinese yuan and the U.S. dollar versus the Brazilian real. Foreign currency debt and foreign exchange forward contracts are used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts are also used to hedge firm and highly anticipated foreign currency cash flows.

To analyze the effects of changing foreign currency rates, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in the foreign currency exchange rates from their levels at September 30, 2014 and December 31, 2013, with all other variables (including interest rates) held constant.

*(in Millions)*

|  | Net Asset / (Liability) Position | Hedged currency vs. Functional currency 10% Strengthening | 10% Weakening |
| --- | ---: | ---: | ---: |
| **Net asset/(liability) position at September 30, 2014** | $3.1 | $(133.4) (1) | $140.4 (1) |
| **Net asset/(liability) position at December 31, 2013** | $(6.5) | $9.1 | $(21.0) |

(1) The large fluctuations in the hedged vs. functional currency analysis is driven by the derivative contracts entered into to hedge the purchase price of Cheminova A/S, which approximate a notional value of $1.6 billion.

### Interest Rate Risk

One of the strategies that we can use to manage interest rate exposure is to enter into interest rate swap agreements. In these agreements, we agree to exchange, at specified intervals, the difference between fixed and variable interest amounts calculated on an agreed-upon notional principal amount. As of September 30, 2014 and December 31, 2013, we had no interest rate swap agreements.

Our debt portfolio, at September 30, 2014, is composed of 68 percent fixed-rate debt and 32 percent variable-rate debt. The variable-rate component of our debt portfolio principally consists of borrowings under our revolving credit facility, commercial paper program, variable-rate industrial and pollution control revenue bonds, and amounts outstanding under foreign subsidiary credit lines. Changes in interest rates affect different portions of our variable-rate debt portfolio in different ways.

Based on the variable-rate debt in our debt portfolio at September 30, 2014, a one percentage point increase in interest rates then in effect would have increased gross interest expense by $4.2 million and a one percentage point decrease in interest rates then in effect would have decreased gross interest expense by $1.5 million for the nine months of September 30, 2014.

## Market risk

As filed, 207 characters.

The information required by this item is provided in “Derivative Financial Instruments and Market Risks,” under ITEM 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations.

## Controls and procedures

As filed, 3,507 characters.

(a) Evaluation of disclosure controls and procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of September 30, 2014, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Change in Internal Controls. There have been no changes in internal control over financial reporting that occurred during the quarter ended September 30, 2014, that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

### REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Shareholders

FMC Corporation:

We have reviewed the condensed consolidated balance sheet of FMC Corporation and subsidiaries as of September 30, 2014, the related condensed consolidated statements of income and comprehensive income for the three-month and nine-month periods ended September 30, 2014 and 2013, and the related condensed consolidated statements of cash flows for the nine-month periods ended September 30, 2014 and 2013. These condensed consolidated financial statements are the responsibility of the Company’s management.

We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of FMC Corporation and subsidiaries as of December 31, 2013, and the related consolidated statements of income, comprehensive income, cash flows, and changes in equity for the year then ended (not presented herein); and in our report dated February 18, 2014, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2013, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

**/s/** KPMG LLP

Philadelphia, Pennsylvania

October 30, 2014

## Risk factors

As filed, 500 characters.

In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Part 1, Item 1A "Risk Factors" of our 2013 Form 10-K. The risks described in our Form 10-K are not the only risks that we face. Additional risks not presently known to us or that we do not currently consider significant may also have an adverse effect on us. If any of the risks actually occur, our business, results of operations, cash flows or financial condition could suffer.

Filed Oct 30, 2014.
Source: SEC EDGAR, the filing index for accession 0000037785-14-000045. Last ingested by Listed: Nov 13, 2026, 16:31 ET. No prices; not investment advice.
